Resverlogix

Provider of small molecule BET-inhibitors for CV disease for treating diabetes

placeCalgary, Alberta, Canada calendar_todayFounded 2001 groups19 employees language resverlogix.com

Social engagement

Social engagement: 1.9K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Private equity240%
Other / undisclosed240%

Recent activity

18 Nov 2025
Leadership hire
Board of Directors
Coming soon